Growth Metrics

Evaxion A (EVAX) Consolidated Net Income (2020 - 2026)

Evaxion A posted quarterly Consolidated Net Income of -$3.4 million for Q1 2026, down 73.01% year-on-year from -$12.6 million in Q1 2025, and down 264.2% on a QoQ basis from -$933000.0 in Q4 2025.

Evaxion A (EVAX) has 7 years of Consolidated Net Income data on file, last reported at -$3.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Consolidated Net Income fell 73.01% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$2.7 million (up 81.54% YoY), and the FY2025 full-year result was -$9.5 million, up 21.58% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at -$3.4 million, down from -$933000.0 in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $6.8 million in Q3 2025 and bottomed at -$7.2 million in Q4 2022.
  • The 5-year median for Consolidated Net Income is -$5.1 million (2022), against an average of -$3.8 million.
  • Peak annual rise in Consolidated Net Income reached 420.03% in 2025, while the deepest fall reached 359.1% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$7.2 million in 2022, then jumped by 32.43% to -$4.9 million in 2023, then grew by 14.31% to -$4.2 million in 2024, then surged by 77.67% to -$933000.0 in 2025, then tumbled by 264.2% to -$3.4 million in 2026.
  • The last three Consolidated Net Income figures came in at -$3.4 million (Q1 2026), -$933000.0 (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -8.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.40 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 205.99 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn - -453.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.40 Mn
Dec 31, 2025 -933,000.00
Sep 30, 2025 6.81 Mn
Jun 30, 2025 -5.22 Mn
Mar 31, 2025 -1.96 Mn
Dec 31, 2024 -4.18 Mn
Sep 30, 2024 -2.13 Mn
Jun 30, 2024 -6.60 Mn
Mar 31, 2024 758,000.00
Dec 31, 2023 -4.88 Mn
Sep 30, 2023 -6.07 Mn
Jun 30, 2023 -6.13 Mn
Mar 31, 2023 -6.63 Mn
Dec 31, 2022 -7.22 Mn
Sep 30, 2022 -6.09 Mn
Jun 30, 2022 -5.12 Mn
Mar 31, 2022 -6.29 Mn
Dec 31, 2021 -5.72 Mn
Sep 30, 2021 -6.10 Mn
Jun 30, 2021 -8.16 Mn
Mar 31, 2021 -4.91 Mn
Dec 31, 2020 -5.28 Mn
Sep 30, 2020 -5.17 Mn
Jun 30, 2020 -4.23 Mn
Mar 31, 2020 -3.46 Mn